Clinical Trial Update: Nicotinic Acid for the Treatment of Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial of nicotinic acid (niacin) for Alzheimer's disease, sponsored by Indiana University, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Nicotinic acid (niacin)

Snippet

Sponsor: Indiana University | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: RECRUITING